www.fdanews.com/articles/201976-biocorp-diabeloop-partner-on-automated-diabetes-management-devices
BIOCORP, Diabeloop Partner on Automated Diabetes Management Devices
March 23, 2021
BIOCORP and Diabeloop have announced a cooperation agreement to develop new, personalized treatment devices for diabetes patients.
BIOCORP developed and sells Mallya, an intelligent sensor for insulin-injection pens that monitors doses, while Diabeloop has developed automated insulin-delivery systems, including a self-learning handset that connects to a continuous glucose-monitoring solution and insulin pump.
The agreement will combine Diabeloop’s automated solutions with BIOCORP’s insulin-pen technology.